ロード中...

Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase

Entecavir (ETV) is a potent antiviral nucleoside analogue that is used to treat hepatitis B virus (HBV) infection. Recent clinical studies have demonstrated that ETV is also active against the human immunodeficiency virus type 1 (HIV-1). Unlike all approved nucleoside analogue reverse transcriptase...

詳細記述

保存先:
書誌詳細
主要な著者: Tchesnokov, Egor P., Obikhod, Aleksandr, Schinazi, Raymond F., Götte, Matthias
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Biochemistry and Molecular Biology 2008
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2590697/
https://ncbi.nlm.nih.gov/pubmed/18940786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M806797200
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!